| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.008 |